Kathmere Capital Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1794543
WAYNE, PA
Position in VRTX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$218,358
-$22,833 QoQ
Shares Held
489
-15.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kathmere Capital Management, LLC holds $1,009,558 across 7 Biotechnology names. VRTX ranks #2 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SXTP |
60 Degrees Pharmaceuticals, Inc.
|
144,683 | $253,195 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
489 | $218,358 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
29,779 | $190,287 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
11,243 | $166,621 | |
| 5 | ARTL |
Artelo Biosciences, Inc.
|
13,250 | $100,435 | |
| 6 | ORMP |
Oramed Pharmaceuticals Inc.
|
15,071 | $51,241 | |
| 7 | BDTX |
Black Diamond Therapeutics, Inc.
|
13,813 | $29,421 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $218,358 | 489 | Shares | Sole | 2026-04-28 | |
| 2024-03-31 | $241,191 | 577 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $213,617 | 525 | Shares | Sole | 2024-04-16 | |
| 2020-12-31 | $23,634 | 100 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||